DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "European Next-generation Sequencing Services Market, Forecast to 2023" report to their offering.
The European NGS services market is forecast to grow at a CAGR of 15.4% from 2016 to 2023 to reach $605 million by 2023.
A relatively slow adopter of the technology, Europe now contributes to roughly a third of the global NGS services market size. Government-backed large-scale projects in the region such as the 100,000 Genomes Project of the United Kingdom (UK) and France Genomic Medicine Plan 2025 are poised to bring NGS to the forefront. Industry stakeholders are adapting to current market needs and aligning services with growth opportunities in research and clinical applications.
Disruptive technologies in NGS are revolutionizing the healthcare industry. Launch of high-throughput sequencers has set new service standards, with focus on superior coverage and accuracy. Low-cost and quick turnaround features have amplified NGS uptake as an alternative to traditional methods such as microarray, capillary electrophoresis, and Sanger, propelling the demand for NGS services across areas such as human genetics, plant and animal biotech, agriculture, food and drug safety, and forensics.
The research service explores current industry trends and market response to the growing sequencing demand. The NGS services market in Europe has been comprehensively studied to understand the core value proposition of game-changing service providers. Industry-wide collaborations, focusing on diversified applications and value-added services, have also been discussed.
Key Topics Covered:
1. Executive Dashboard
2. Growth Environment-Market Overview
3. Market Forecasts
4. Competitive Playbook
5. Visioning Scenarios
6. Growth Pipeline, Strategy and Implementation
7. The Last Word
For more information about this report visit http://www.researchandmarkets.com/research/qx46wf/european